SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-049423
Filing Date
2020-11-02
Accepted
2020-11-02 06:32:07
Documents
67
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q apls-10q_20200930.htm   iXBRL 10-Q 3014615
2 EX-10.2 apls-ex102_46.htm EX-10.2 5290
3 EX-31.1 apls-ex311_6.htm EX-31.1 18440
4 EX-31.2 apls-ex312_9.htm EX-31.2 17555
5 EX-32.1 apls-ex321_7.htm EX-32.1 8566
6 EX-32.2 apls-ex322_8.htm EX-32.2 8580
  Complete submission text file 0001564590-20-049423.txt   8683637

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA apls-20200930.xsd EX-101.SCH 52315
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apls-20200930_cal.xml EX-101.CAL 45712
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apls-20200930_def.xml EX-101.DEF 170418
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE apls-20200930_lab.xml EX-101.LAB 386399
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apls-20200930_pre.xml EX-101.PRE 306716
12 EXTRACTED XBRL INSTANCE DOCUMENT apls-10q_20200930_htm.xml XML 1438481
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38276 | Film No.: 201278914
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences